BCIQ Profiles

Company Profile Report

Gottlieb rebukes Nostrum’s 300% price hike for generic antibiotic

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Tuesday.


Read the full 299 word article

How to gain access

Continue reading with a
two-week free trial.